Europe Veterinary Oncology Market Size & Outlook, 2026-2033
The veterinary oncology market in Europe is expected to reach a projected revenue of US$ 1,573.0 million by 2033. A compound annual growth rate of 14.4% is expected of Europe veterinary oncology market from 2026 to 2033.
- Animal Health
- Veterinary Services & IT
- Veterinary Oncology Market Outlook
- Veterinary Services & IT
Revenue, 2025 (US$M)
$536.8
Estimate, 2026 (US$M)
$614.3
Forecast, 2033 (US$M)
$1,573.0
CAGR, 2026 - 2033
14.4%
Europe Veterinary Oncology Market, 2021-2033 (US$M)
Global Report
Related Markets
Prism AI by Grand View ResearchFree to try
Ask a question about the veterinary oncology market
Every figure cited from GVR research
Europe veterinary oncology market outlook highlights
- The Europe veterinary oncology market outlook generated a revenue of USD 536.8 million in 2025.
- The market is expected to grow at a CAGR of 14.4% from 2026 to 2033.
- In terms of segment, canine was the largest revenue generating animal type in 2025.
- Canine is the most lucrative animal type segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 536.8 million |
| Market revenue in 2033 | USD 1,573.0 million |
| Growth rate | 14.4% (CAGR from 2026 to 2033) |
| Largest segment | Canine |
| Fastest growing segment | Canine |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Canine, Feline, Equine |
| Key market players worldwide | Zoetis Inc Class A, Karyopharm Therapeutics Inc, Varian, Accuray Inc, Petcure Oncology, Boehringer Ingelheim, Elanco Animal Health Inc, One Health Group, Regeneus |
Other key industry trends
- In terms of revenue, Europe region accounted for 30.5% of the veterinary oncology market outlook in 2025. Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Europe is the fastest growing regional market and is projected to reach USD 1,573.0 million by 2033.
No credit card required*
Publish Date: Nov 02, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Oncology Market Scope
Veterinary Oncology Market segmentation & scope
Veterinary Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Zoetis Inc Class A | View profile | 14,100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | www.zoetis.com |
| Elanco Animal Health Inc | View profile | 9,800 | 2500 Innovation Way, Greenfield, IN, United States, 46140 | www.elanco.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | www.boehringer-ingelheim.com/ |
| Accuray Inc | View profile | 1,024 | 1240 Deming Way, Madison, WI, United States, 53717 | www.accuray.com |
| Varian | View profile | 5001-10000 | Palo Alto, California, United States, North America | www.varian.com/ |
| Karyopharm Therapeutics Inc | View profile | 325 | 85 Wells Avenue, 2nd Floor, Newton, MA, United States, 02459 | www.karyopharm.com |
| PetCure Oncology | View profile | 11-50 | Deerfield, Illinois, United States, North America | petcureoncology.com/ |
| One Health Group | View profile | 1-10 | Cazenovia, New York, United States, North America | www.onehealthgroup.com/ |
| Regeneus | View profile | 11-50 | Pymble, New South Wales, Australia, Oceania | regeneus.com.au/ |
Europe Veterinary Oncology Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Veterinary Oncology Market Outlook will help companies and investors design strategic landscapes.
Canine was the largest segment with a revenue share of 99.35% in 2025.
Horizon Databook has segmented the Europe veterinary oncology market based on canine, feline, equine covering the revenue growth of each sub-segment from 2021 to 2033.
- Europe Veterinary Oncology Market Animal Type Outlook (Revenue, USD Million , 2021-2033)
- Canine
- Feline
- Equine
- Europe Veterinary Oncology Market Therapy Outlook (Revenue, USD Million , 2021-2033)
- Radiotherapy
- Surgery
- Chemotherapy
- Immunotherapy
- Other
- Europe Veterinary Oncology Market Cancer Type Outlook (Revenue, USD Million , 2021-2033)
- Skin Cancers
- Lymphomas
- Sarcomas
- Others
Reasons to subscribe to Veterinary Oncology Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Veterinary Oncology Market Outlook databook
- Our clientele includes a mix of Veterinary Oncology Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Veterinary Oncology Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Veterinary Oncology Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Veterinary Oncology Market, 2021-2033 (US$M)
Europe veterinary oncology market statistics, by animal type 2021 - 2033 (US$M)
